3
Announcements
Trials
Browse
Landscape
Status
Terminated
2
Completed
2
Active not recruiting
2
Withdrawn
1
Unknown
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
20
INDUSTRY
3
NIH
1
NETWORK
1
Study Type
Observational
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Melanoma
3
Leukemia, Myeloid, Acute
3
Carcinoma, Non-Small-Cell Lung
3
Sarcoma, Kaposi
2
Sarcoma, Alveolar Soft Part
2
Prostatic Neoplasms
2
Non-Muscle Invasive Bladder Neoplasms
2
Lymphoma
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Urinary Incontinence
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Solid Tumor
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neurofibrosarcoma
1
Neoplasms
1
Musculoskeletal Pain
1
Multiple Myeloma
1
Malignant Solid Neoplasm
1
Lymphoma, Non-Hodgkin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
NETWORK
×
Carcinoma
×
Clear all
NCT06630273
2026-03-27
(CAN-IMPACT-IO
Canadian Cancer Trials Group
Not yet recruiting
120 enrolled